Get the facts on diseases, conditions, tests and procedures.
Enter the last name, specialty or keyword for your search below.
Nearly 20 years after a pioneering bone marrow transplant saved his life, Michael Billig found himself back at Johns Hopkins, once again putting his trust in a team of “hematological masters of the universe.”
For hospital-bound patients—and the clinicians who serve them—the gift of music is proving a spirit-lifting balm.
Graduates of the Berman Institute’s new master’s program appear to be hot commodities, as employers—from industry to government agencies—aim to bring a more ethical lens to their work.
Meet four Johns Hopkins “greats” who made seminal contributions in the early years of the school of medicine—and their contemporary counterparts who have grabbed the baton to move their fields forward farther still.
For decades, a definitive diagnosis for Mike Goldberg ’03 proved elusive. Now, by laying the foundation to find treatments for his “orphan disease,” he and his family hope to create a model for others.
Robert Macauley’s new book is certain to become a landmark text on the complicated, challenging and inextricably entwined fields of palliative care and biomedical ethics.
A recent gift aims to change that. Johns Hopkins recently received a pledge of $50 million from the United Arab Emirates to launch the Sheikh Khalifa Stroke Institute.
A Johns Hopkins team has developed a new approach that uses algorithms to mine clinical and billing data to spot certain symptoms that are often misdiagnosed.
As we mark the 125th anniversary of the Johns Hopkins University School of Medicine, we have been recounting some of the stories that have played out in the shadow of the dome over the years.
Advances in surgical precision, safety and outcomes require that we bury complexity in the OR. Enter a new kind of engineer.
With the recent opening of the Skip Viragh Outpatient Cancer Building, the Johns Hopkins Kimmel Cancer Center has a new hub for cancer services and clinical research. “Cancer treatment now more than ever is being treated on an individual platform and in an outpatient setting. This building is designed to provide care and comfort to those patients,” says William Nelson, director of the Kimmel Cancer Cancer.
Located at 201 N. Broadway, the new $100 million cancer building serves patients with solid tumors, such as breast, lung, colon and bladder. Patients with non-solid tumor cancers (such as leukemia and lymphoma) will continue to receive their care at the Harry and Jeanette Weinberg Building.
Watch a video to find out more about the Viragh Outpatient Cancer Building and Skip Viragh, whose gift and vision helped make it possible.
You can choose to support a specific cause at Johns Hopkins about which you are passionate, or you can make a contribution that will support our priorities in research, patient care and medical education.
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
